Reprogramming Medulloblastoma-Propagating Cells by a Combined Antagonism of Sonic Hedgehog and CXCR4.

about

Reprogramming Medulloblastoma-Propagating Cells by a Combined Antagonism of Sonic Hedgehog and CXCR4.

Item

http://www.wikidata.org/entity/Q51230315

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh-hant

name

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@en

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@nl

type

Item

label

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@en

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@nl

prefLabel

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@en

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@nl

P1476

Reprogramming Medulloblastoma- ...... m of Sonic Hedgehog and CXCR4.

@en

P2093

Jingqin Luo

http://www.w3.org/2001/XMLSchema#string

Joshua B Rubin

http://www.w3.org/2001/XMLSchema#string

Najla Kfoury

http://www.w3.org/2001/XMLSchema#string

Nicole M Warrington

http://www.w3.org/2001/XMLSchema#string

Sara Taylor

http://www.w3.org/2001/XMLSchema#string

Stacey A Ward

http://www.w3.org/2001/XMLSchema#string

P2860

Smoothened mutation confers resistance to a Hedgehog pathway inhibitor in medulloblastoma.

Genome sequencing of SHH medulloblastoma predicts genotype-related response to smoothened inhibition

Smoothened variants explain the majority of drug resistance in basal cell carcinoma

Vismodegib Exerts Targeted Efficacy Against Recurrent Sonic Hedgehog-Subgroup Medulloblastoma: Results From Phase II Pediatric Brain Tumor Consortium Studies PBTC-025B and PBTC-032.

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

Cancer stem cells and "stemness" genes in neuro-oncology

Control of neuronal precursor proliferation in the cerebellum by Sonic Hedgehog

Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection.

Pharmacokinetics and safety of AMD-3100, a novel antagonist of the CXCR-4 chemokine receptor, in human volunteers.

Sexually dimorphic RB inactivation underlies mesenchymal glioblastoma prevalence in males

P304

1416-1426

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-16-0847

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28031228

http://www.w3.org/2001/XMLSchema#string

P921

medulloblastoma

P932

5505622

http://www.w3.org/2001/XMLSchema#string